About the journal
Targets is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2813-3137
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 CHF
- Articles in DOAJ
- 30
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.mdpi.com/journal/targets
Index listings
- DOAJ · 2026-01-12
- Indexing
- DOAJ
- APC
- 1,000 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
30
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
92
Last recorded publication year
2026
h-index
8
i10-index
6
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-01-12
- Added to DOAJ
- 2026-01-12
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 90%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918976360906676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- Computational Drug Discovery Methods
- Nanoplatforms for cancer theranostics
- Computational Drug Discovery Methods
- Nanoplatforms for cancer theranostics
- RNA Interference and Gene Delivery
- Alzheimer's disease research and treatments
Show all subjects (50)
- Lung Cancer Treatments and Mutations
- Monoclonal and Polyclonal Antibodies Research
- Alzheimer's disease research and treatments
- RNA Interference and Gene Delivery
- Monoclonal and Polyclonal Antibodies Research
- Lung Cancer Treatments and Mutations
- Extracellular vesicles in disease
- Protein Degradation and Inhibitors
- Sulfur Compounds in Biology
- Cancer Genomics and Diagnostics
- PI3K/AKT/mTOR signaling in cancer
- Chemical Synthesis and Analysis
- Estrogen and related hormone effects
- Protease and Inhibitor Mechanisms
- Epigenetics and DNA Methylation
- Breast Cancer Treatment Studies
- Molecular Sensors and Ion Detection
- Ferroptosis and cancer prognosis
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Estrogen and related hormone effects
- Chemical Synthesis and Analysis
- PI3K/AKT/mTOR signaling in cancer
- Cancer Genomics and Diagnostics
- Sulfur Compounds in Biology
- Protein Degradation and Inhibitors
- Molecular Sensors and Ion Detection
- Biosensors and Analytical Detection
- Luminescence and Fluorescent Materials
- Cholinesterase and Neurodegenerative Diseases
- Sirtuins and Resveratrol in Medicine
- Biosensors and Analytical Detection
- Luminescence and Fluorescent Materials
- Sirtuins and Resveratrol in Medicine
- Cholinesterase and Neurodegenerative Diseases
- MicroRNA in disease regulation
- Glioma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- MicroRNA in disease regulation
- Nanoparticle-Based Drug Delivery
- Neuroscience and Neuropharmacology Research
- Nanoparticle-Based Drug Delivery
Keywords (DOAJ)
- biological interaction
- molecular analysis
- drug targeting
- targeted therapy
- diagnostic biomarkers
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ